or Try an Advanced Search...

    Technical Analysis for CVM - Cel-Sci Corporation

    Grade Last Price % Change Price Change
    F 1.44 3.60% 0.05
    CVM closed up 3.6 percent on Wednesday, May 15, 2024, on 83 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong Down Down Down
    Historical CVM trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish 3.60%
    Calm After Storm Range Contraction 3.60%
    Outside Day Range Expansion 3.60%
    Oversold Stochastic Weakness 3.60%
    Calm After Storm Range Contraction 1.41%
    NR7 Range Contraction 1.41%
    Older End-of-Day Signals for CVM ...

       Recent Intraday Alerts

    Alert Time
    20 DMA Resistance about 21 hours ago
    10 DMA Resistance about 21 hours ago
    1.5x Volume Pace about 21 hours ago
    Up 5% about 21 hours ago
    Up 3% about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CVM Chart by TradingView
    Basic chart:

    Profile

    Cel-Sci Corporation Description

    CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.

    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Immunology Immune System Immunotherapy Vaccines Autoimmunity Rheumatoid Arthritis Vaccination Transplantation Cytokine Head And Neck Cancer Antigen Immune Response Allergies

    Is CVM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 CEL-SCI gains as FDA greenlights confirmatory study for Multikine
    May 8 CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
    Apr 23 CEL-SCI Appoints Mario Gobbo to Its Board of Directors
    Mar 19 CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology
    Mar 6 CEL-SCI Corporation Issues Letter to Shareholders
    Feb 15 Cel-Sci GAAP EPS of -$0.14
    Feb 15 CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results
    Feb 13 CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock
    Feb 12 Cel-Sci: Fabulous Story Stock Works To Pass Muster With FDA
    Feb 9 CEL-SCI stock falls as it prices its offering to raise $7.75M
    See more CVM news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.23
    52 Week Low 1.04
    Average Volume 340,545
    200-Day Moving Average 1.92
    50-Day Moving Average 1.73
    20-Day Moving Average 1.49
    10-Day Moving Average 1.51
    Average True Range 0.17
    RSI (14) 42.86
    ADX 50.17
    +DI 34.67
    -DI 6.59
    Chandelier Exit (Long, 3 ATRs) 1.87
    Chandelier Exit (Short, 3 ATRs) 1.88
    Upper Bollinger Bands 1.67
    Lower Bollinger Band 1.31
    Percent B (%b) 0.37
    BandWidth 24.09
    MACD Line -0.08
    MACD Signal Line -0.08
    MACD Histogram 0.0075
    Fundamentals Value
    Market Cap 71.97 Million
    Num Shares 50 Million
    EPS -0.73
    Price-to-Earnings (P/E) Ratio -1.97
    Price-to-Sales 11797.42
    Price-to-Book 9.30
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.64
    Resistance 3 (R3) 1.64 1.57 1.60
    Resistance 2 (R2) 1.57 1.52 1.57 1.59
    Resistance 1 (R1) 1.51 1.49 1.54 1.51 1.58
    Pivot Point 1.44 1.44 1.46 1.44 1.44
    Support 1 (S1) 1.38 1.39 1.41 1.38 1.30
    Support 2 (S2) 1.31 1.36 1.31 1.29
    Support 3 (S3) 1.25 1.31 1.28
    Support 4 (S4) 1.25